GAITHERSBURG, Md. April 14, 2021 / PRNewswire / – Novavax, Inc. (Nasdaq: NVAX), a biotechnology company that develops next-generation vaccines for serious infectious diseases, announced…
26.04.2024
GAITHERSBURG, Md. April 14, 2021 / PRNewswire / – Novavax, Inc. (Nasdaq: NVAX), a biotechnology company that develops next-generation vaccines for serious infectious diseases, announced…